Daclatasvir: a team player rather than a prima donna in the treatment of hepatitis C.
about
SASLT guidelines: Update in treatment of Hepatitis C virus infection.Review article: the efficacy and safety of daclatasvir in the treatment of chronic hepatitis C virus infection.Daclatasvir/peginterferon lambda-1a/ribavirin in patients with chronic HCV infection and haemophilia who are treatment naïve or prior relapsers to peginterferon alfa-2a/ribavirin.New hepatitis C therapies for special patient populations.
P2860
Daclatasvir: a team player rather than a prima donna in the treatment of hepatitis C.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Daclatasvir: a team player rather than a prima donna in the treatment of hepatitis C.
@en
Daclatasvir: a team player rather than a prima donna in the treatment of hepatitis C.
@nl
type
label
Daclatasvir: a team player rather than a prima donna in the treatment of hepatitis C.
@en
Daclatasvir: a team player rather than a prima donna in the treatment of hepatitis C.
@nl
prefLabel
Daclatasvir: a team player rather than a prima donna in the treatment of hepatitis C.
@en
Daclatasvir: a team player rather than a prima donna in the treatment of hepatitis C.
@nl
P2860
P1433
P1476
Daclatasvir: a team player rather than a prima donna in the treatment of hepatitis C
@en
P2093
Alessio Aghemo
P2860
P304
P356
10.1136/GUTJNL-2014-307958
P407
P577
2014-09-05T00:00:00Z